Revvity Comprehensive Income 2010-2024 | RVTY

Revvity comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Revvity comprehensive income for the quarter ending September 30, 2024 was $-0.232B, a 38.85% decline year-over-year.
  • Revvity comprehensive income for 2023 was $-0.277B, a 38.17% decline from 2022.
  • Revvity comprehensive income for 2022 was $-0.447B, a 175.06% increase from 2021.
  • Revvity comprehensive income for 2021 was $-0.163B, a 409.03% increase from 2020.
Revvity Annual Comprehensive Income
(Millions of US $)
2023 $-277
2022 $-447
2021 $-163
2020 $-32
2019 $-200
2018 $-176
2017 $-47
2016 $-101
2015 $-46
2014 $25
2013 $78
2012 $67
2011 $54
2010 $51
2009 $-27
Revvity Quarterly Comprehensive Income
(Millions of US $)
2024-09-30 $-232
2024-06-30 $-342
2024-03-31 $-325
2023-12-31 $-277
2023-09-30 $-379
2023-06-30 $-305
2023-03-31 $-304
2022-12-31 $-447
2022-09-30 $-650
2022-06-30 $-459
2022-03-31 $-247
2021-12-31 $-163
2021-09-30 $-146
2021-06-30 $-92
2021-03-31 $-104
2020-12-31 $-32
2020-09-30 $-144
2020-06-30 $-217
2020-03-31 $-278
2019-12-31 $-200
2019-09-30 $-243
2019-06-30 $-181
2019-03-31 $-174
2018-12-31 $-176
2018-09-30 $-161
2018-06-30 $-131
2018-03-31 $-28
2017-12-31 $-47
2017-09-30 $-54
2017-06-30 $-63
2017-03-31 $-82
2016-12-31 $-101
2016-09-30 $-55
2016-06-30 $-45
2016-03-31 $-14
2015-12-31 $-46
2015-09-30 $-33
2015-06-30 $13
2015-03-31 $1
2014-12-31 $25
2014-09-30 $48
2014-06-30 $81
2014-03-31 $78
2013-12-31 $78
2013-09-30 $69
2013-06-30 $52
2013-03-31 $53
2012-12-31 $67
2012-09-30 $59
2012-06-30 $38
2012-03-31 $68
2011-12-31 $54
2011-09-30 $-31
2011-06-30 $10
2011-03-31 $-6
2010-12-31 $51
2010-09-30 $-45
2010-06-30 $-98
2010-03-31 $-56
2009-12-31 $-27
2009-09-30 $-16
2009-06-30 $-37
2009-03-31 $-79
Sector Industry Market Cap Revenue
Medical Medical Services $14.647B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.766B 11.88
Cencora (COR) United States $49.023B 18.08
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $17.511B 15.60
Natera (NTRA) United States $16.712B 0.00
Viatris (VTRS) United States $15.433B 4.75
Avantor (AVTR) United States $14.831B 22.24
BioMerieux (BMXMF) France $12.894B 0.00
CochLear (CHEOY) Australia $12.739B 0.00
Solventum (SOLV) United States $12.214B 0.00
Medpace Holdings (MEDP) United States $11.215B 31.59
Charles River Laboratories (CRL) United States $11.042B 21.34
Doximity (DOCS) United States $10.778B 63.79
HealthEquity (HQY) United States $8.750B 47.49
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Bausch + Lomb (BLCO) Canada $6.881B 32.03
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.402B 23.55
Organon (OGN) United States $4.012B 4.05
Surgery Partners (SGRY) United States $3.759B 42.85
BrightSpring Health Services (BTSG) United States $3.402B 72.37
PACS (PACS) United States $3.129B 0.00
Concentras Parent (CON) United States $2.579B 0.00
Alignment Healthcare (ALHC) United States $2.523B 0.00
Ardent Health Partners (ARDT) United States $2.446B 0.00
Premier (PINC) United States $2.301B 11.48
GeneDx Holdings (WGS) United States $2.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.783B 47.00
Teladoc Health (TDOC) United States $1.670B 0.00
Progyny (PGNY) United States $1.551B 29.62
Pediatrix Medical (MD) United States $1.331B 13.02
CareDx (CDNA) United States $1.251B 0.00
Establishment Labs Holdings (ESTA) $1.184B 0.00
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Embecta (EMBC) United States $0.898B 5.99
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
InnovAge Holding (INNV) United States $0.778B 0.00
Agilon Health (AGL) United States $0.770B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.442B 0.00
DocGo (DCGO) United States $0.426B 16.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.346B 0.00
LifeMD (LFMD) United States $0.310B 0.00
ModivCare (MODV) United States $0.244B 13.24
Sera Prognostics (SERA) United States $0.242B 0.00
Beauty Health (SKIN) United States $0.211B 0.00
Nutex Health (NUTX) United States $0.204B 0.00
Biodesix (BDSX) United States $0.204B 0.00
MultiPlan (MPLN) United States $0.141B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.073B 17.77
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.051B 0.00
NeueHealth (NEUE) United States $0.042B 1.12
Co-Diagnostics (CODX) United States $0.037B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00